组织黏合剂管道 - 发展阶段、细分市场、地区和国家、监管途径、主要参与者(2024 年版)
市场调查报告书
商品编码
1590402

组织黏合剂管道 - 发展阶段、细分市场、地区和国家、监管途径、主要参与者(2024 年版)

Tissue Adhesives Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

出版日期: | 出版商: GlobalData | 英文 57 Pages | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

本报告提供了有关组织黏合剂管道产品的全面信息,包括处于不同开发阶段的产品的比较分析以及正在进行的临床试验的数据。

目录

第 1 章目录

第 2 章简介

第3章开发中的产品

  • 组织黏合剂 - 管道产品:依开发阶段划分
  • 组织黏合剂 - 管道产品:按细分市场
  • 组织黏合剂 - 管道产品:按地区
  • 组织黏合剂 - 管道产品:依监管途径
  • 组织黏合剂 - 管道产品:预计核准日期
  • 组织黏合剂 - 正在进行的临床试验

第 4 章组织黏合剂 - 各公司正在开发的管道产品

  • 组织黏合剂公司 - 管道产品:依发展阶段划分
  • 组织黏合剂 - 管道产品:依开发阶段划分

第五章组织黏合剂企业及产品概述

  • Adhesys Medical GmbH:公司概况
    • Adhesys Medical GmbH:管道产品和正在进行的临床试验概述
  • Advanced Medical Solutions Group plc:公司概况
    • Advanced Medical Solutions Group plc:管道产品和正在进行的临床试验概述
  • Aleo BME Inc:公司概况
    • Aleo BME Inc:管道产品和正在进行的临床试验概述
  • Alumend LLC:公司概况
    • Alumend LLC:管道产品和正在进行的临床试验概述
  • Artivion Inc:公司概况
    • Artivion Inc:管道产品和正在进行的临床试验概述
  • BioDevek Inc:公司概况
    • BioDevek Inc:管道产品和正在进行的临床试验概述
  • DialyFlux LLC:公司概况
    • DialyFlux LLC:管道产品和正在进行的临床试验概述
  • 埃默里大学:公司概况
    • 埃默里大学:管道产品和正在进行的临床试验概述
  • Hansjorg Wyss 仿生工程研究所:公司概况
    • Hansjorg Wyss 生物启发工程研究所:管道产品和正在进行的临床试验概述
  • 哈佛大学:公司概况
    • 哈佛大学:管道产品和正在进行的临床试验概述
  • Kollodis BioSciences Inc:公司概况
    • Kollodis BioSciences Inc:管道产品和正在进行的临床试验概述
  • 麻省理工学院:公司概况
    • 麻省理工学院:管道产品和正在进行的临床试验概述
  • Medisse BV(不活跃):公司概览
    • Medisse BV(不活跃):管道产品和正在进行的临床试验概述
  • N8 Medical LLC:公司概况
    • N8 Medical LLC:管道产品和正在进行的临床试验概述
  • 南洋理工大学:公司概况
    • 南洋理工大学:管道产品和正在进行的临床试验概述
  • 西北大学:公司概况
    • 西北大学:管道产品和正在进行的临床试验概述
  • OptMed Inc:公司概况
    • OptMed Inc:管道产品和正在进行的临床试验概述
  • 普渡大学:公司概况
    • 普渡大学:管道产品和正在进行的临床试验概述
  • Tissium SA:公司概况
    • Tissium SA:管道产品和正在进行的临床试验概述
  • 戈尔韦大学:公司概况
    • 戈尔韦大学:管道产品和正在进行的临床试验概述
  • 堪萨斯大学:公司概况
    • 堪萨斯大学:管道产品和正在进行的临床试验概述

第 6 章组织黏合剂 - 最新进展

  • 2024 年 8 月 30 日:Okapi Medical 获得 Cutiva 局部皮肤黏合剂的 510(k) 许可
  • 2024 年 7 月 29 日:Connexicon Medical 获得 FDA 510(k) CM005 标准 (CM005) 许可
  • 2024 年 7 月 29 日:Connexicon Medical 的 CM00622 LINC 皮肤闭合系统 (CM00622 LINC) 获得 FDA 510(k) 许可
  • 2024 年 7 月 29 日:Connexicon 获得 FDA 510(k) CM004 Mini (CM004) 许可
  • 2024 年 3 月 22 日:Meril Endo 手术公司的 Meriglu 局部皮肤黏合剂获得 FDA 510(K) 批准
  • 2023 年 10 月 18 日:NeoDyne 在英国开设新总部,庆祝在英国的成长与扩张

第7章附录

Product Code: GDME1861EPD

GlobalData's Medical Devices sector report, "Tissue Adhesives Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Tissue Adhesives pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue adhesives consist of polymers that form a thin protective film and create a strong adherent bond to hold the edges of wounds on the skin. Tissue adhesives allows for proper healing of the wound under the film and protects the wound from microbial infections.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Tissue Adhesives under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Adhesives and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Adhesives under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Tissue Adhesives Overview

3 Products under Development

  • 3.1 Tissue Adhesives - Pipeline Products by Stage of Development
  • 3.2 Tissue Adhesives - Pipeline Products by Segment
  • 3.3 Tissue Adhesives - Pipeline Products by Territory
  • 3.4 Tissue Adhesives - Pipeline Products by Regulatory Path
  • 3.5 Tissue Adhesives - Pipeline Products by Estimated Approval Date
  • 3.6 Tissue Adhesives - Ongoing Clinical Trials

4 Tissue Adhesives - Pipeline Products under Development by Companies

  • 4.1 Tissue Adhesives Companies - Pipeline Products by Stage of Development
  • 4.2 Tissue Adhesives - Pipeline Products by Stage of Development

5 Tissue Adhesives Companies and Product Overview

  • 5.1 Adhesys Medical GmbH Company Overview
    • 5.1.1 Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Advanced Medical Solutions Group plc Company Overview
    • 5.2.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Aleo BME Inc Company Overview
    • 5.3.1 Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Alumend LLC Company Overview
    • 5.4.1 Alumend LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Artivion Inc Company Overview
    • 5.5.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 BioDevek Inc Company Overview
    • 5.6.1 BioDevek Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 DialyFlux LLC Company Overview
    • 5.7.1 DialyFlux LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Emory University Company Overview
    • 5.8.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview
    • 5.9.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Harvard University Company Overview
    • 5.10.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Kollodis BioSciences Inc Company Overview
    • 5.11.1 Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Massachusetts Institute of Technology Company Overview
    • 5.12.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Medisse BV (Inactive) Company Overview
    • 5.13.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 N8 Medical LLC Company Overview
    • 5.14.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Nanyang Technological University Company Overview
    • 5.15.1 Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Northwestern University Company Overview
    • 5.16.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 OptMed Inc Company Overview
    • 5.17.1 OptMed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Purdue University Company Overview
    • 5.18.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 Tissium SA Company Overview
    • 5.19.1 Tissium SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 University of Galway Company Overview
    • 5.20.1 University of Galway Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 University of Kansas Company Overview
    • 5.21.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview

6 Tissue Adhesives- Recent Developments

  • 6.1 Aug 30, 2024: Okapi Medical Receives 510(k) Clearance For Cutiva Topical Skin Adhesive
  • 6.2 Jul 29, 2024: Connexicon Medical Receives FDA 510(k) Clearance for CM005 Standard (CM005)
  • 6.3 Jul 29, 2024: Connexicon Medical Receives FDA 510(k) Clearance for CM00622 LINC Skin Closure System (CM00622 LINC)
  • 6.4 Jul 29, 2024: Connexicon Receives FDA 510(k) Clearance for CM004 Mini (CM004)
  • 6.5 Mar 22, 2024: Meril Endo Surgery Received FDA 510(K) Clearance For Meriglu Topical Skin Adhesive
  • 6.6 Oct 18, 2023: NeoDyne Launches New UK Headquarters to Mark Growth and Expansion in the UK

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

  • Tissue Adhesives - Pipeline Products by Stage of Development
  • Tissue Adhesives - Pipeline Products by Segment
  • Tissue Adhesives - Pipeline Products by Territory
  • Tissue Adhesives - Pipeline Products by Regulatory Path
  • Tissue Adhesives - Pipeline Products by Estimated Approval Date
  • Tissue Adhesives - Ongoing Clinical Trials
  • Tissue Adhesives Companies - Pipeline Products by Stage of Development
  • Tissue Adhesives - Pipeline Products by Stage of Development
  • Glossary

List of Figures

  • Tissue Adhesives - Pipeline Products by Stage of Development
  • Tissue Adhesives - Pipeline Products by Segment
  • Tissue Adhesives - Pipeline Products by Territory
  • Tissue Adhesives - Pipeline Products by Regulatory Path
  • Tissue Adhesives - Pipeline Products by Estimated Approval Date
  • Tissue Adhesives - Ongoing Clinical Trials